ORIC PHARMACEUTICALS INC (ORIC) Stock Balance Sheet
USA - NASDAQ:ORIC - US68622P1093 - Common Stock
12.355 USD
-0.8 (-6.12%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 75.86M | 59.41M | 23.38M | 66.80M | 226.00M | |||
| Marketable Securities | 206.65M | 196.55M | 184.80M | 139.40M | 11.00M | |||
| Other Current Assets | 8.61M | 6.29M | 4.41M | 4.20M | 3.50M | |||
| Total Current Assets | 291.12M | 262.25M | 212.60M | 210.50M | 240.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.76M | 11.30M | 2.86M | 3.30M | 2.40M | |||
| Investments And Advances | 45.22M | 0.00 | 26.85M | 22.00M | 43.40M | |||
| Other Non-Current Assets | 7.75M | 588.00K | 9.70M | 11.50M | 12.30M | |||
| Total Non-Current Assets | 55.73M | 11.89M | 39.41M | 36.70M | 58.10M | |||
| TOTAL ASSETS | 346.86M | 274.14M | 252.01M | 247.20M | 298.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.92M | 23.30M | 19.51M | 14.10M | 13.30M | |||
| Accounts Payable | 3.13M | 1.55M | 944.00K | 1.30M | 1.90M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 18.05M | 24.85M | 20.46M | 15.40M | 15.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.81M | 6.17M | 7.46M | 9.40M | 10.50M | |||
| Total Non-Current Liabilities | 4.81M | 6.17M | 7.46M | 9.40M | 10.50M | |||
| TOTAL LIABILITIES | 22.86M | 31.02M | 27.92M | 24.80M | 25.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -628.96M | -562.39M | -434.67M | -335.50M | -245.20M | |||
| Additional Paid In Capital | 952.95M | 805.51M | 658.75M | 557.90M | 518.20M | |||
| Common Shares | 9.00K | 7.00K | 6.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 86.19M | 71.02M | 54.87M | 45.10M | 39.40M | |||
| Tangible Book Value per Share | 3.76 | 3.42 | 4.08 | 4.93 | 6.93 | |||
| Total Shareholders' Equity | 324.00M | 243.12M | 224.09M | 222.40M | 273.00M | |||
| TOTAL LIABILITIES AND EQUITY | 346.86M | 274.14M | 252.01M | 247.20M | 298.60M | |||
| Statistics | ||||||||
| Current Ratio | 16.13 | 10.56 | 10.39 | 13.67 | 15.82 | |||
| Return On Assets (ROA) | -39.69% | -46.64% | -39.96% | -36.05% | -26.36% | |||
| Return On Equity (ROE) | -42.50% | -52.59% | -44.94% | -40.07% | -28.84% | |||
All data in USD , ROIC based on taxRate of 0.21